Tumor regression mechanisms by IL-13 receptor-targeted cancer therapy involve apoptotic pathways
Open Access
- 26 November 2002
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 103 (1) , 45-52
- https://doi.org/10.1002/ijc.10778
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Apoptotic pathways of cell death induced by an interleukin-13 receptor-targeted recombinant cytotoxin in head and neck cancer cellsCancer Immunology, Immunotherapy, 2002
- The biochemistry of apoptosisNature, 2000
- Caspases: Enemies WithinScience, 1998
- Death Receptors: Signaling and ModulationScience, 1998
- Mitochondria and ApoptosisScience, 1998
- Interleukin-13 Receptors on Human Prostate Carcinoma Cell Lines Represent a Novel Target for a Chimeric Protein Composed of IL-13 and a Mutated Form of Pseudomonas ExotoxinJournal of Urology, 1997
- Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria BlockedScience, 1997
- The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of ApoptosisScience, 1997
- A Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin Is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4Journal of Biological Chemistry, 1995
- Receptor for Interleukin 13Journal of Biological Chemistry, 1995